Menu Search
Equities

Starpharma Holdings Ltd

PQ6:STU

Starpharma Holdings Ltd

Actions
  • Price (EUR)0.0565
  • Today's Change-0.003 / -5.04%
  • Shares traded0.00
  • 1 Year change-33.92%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Starpharma Holdings Ltd grew revenues 131.84% from 4.21m to 9.76m while net income improved from a loss of 15.64m to a smaller loss of 8.17m.
Gross margin93.52%
Net profit margin-83.69%
Operating margin-83.69%
Return on assets-18.37%
Return on equity-25.95%
Return on investment-24.10%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Starpharma Holdings Ltd fell by 11.82m. Cash Flow from Investing was negative at 89.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 6.98m for operations while cash used for financing totalled 4.75m.
Cash flow per share-0.0171
Price/Cash flow per share--
Book value per share0.0682
Tangible book value per share0.0682
More ▼

Balance sheet in AUDView more

Starpharma Holdings Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.53% of the market capitalization can be attributed to its 23.36m and debt could be paid in full if management chose.
Current ratio4.94
Quick ratio4.58
Total debt/total equity0.1255
Total debt/total capital0.1115
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.